The methods and uses described herein relate to the modulation of the immune system by modulation of Sema3F levels and/or activity, e.g. suppressing allograft rejection or inflammation by administering a Sema3F agonist or increasing an immune response by administering a Sema3F inhibitor.
Evelo Biosciences
Scientist
Amgen
Scientist
Boston Children's Hospital 2009 - Jan 2015
Research Fellow
Dana-Farber Cancer Institute Aug 2007 - Apr 2009
Postdoc
Universitätsspital Basel Mar 2004 - Jun 2007
Phd Graduate Student
Education:
Universität Greifswald 1999 - 2002
The University of Göttingen 1998 - 1999
University of Erlangen - Nuremberg 1996 - 1998
University of Basel
Doctorates, Doctor of Philosophy, Philosophy, Immunology
Skills:
Cell Biology Flow Cytometry Molecular Biology Immunology Cell Culture Animal Models Immunohistochemistry Western Blotting Life Sciences Qpcr Biochemistry Pcr Cancer Research Elisa In Vitro In Vivo Cell Transfection Transgenic Mice Western Blot Cell Sorting Real Time Polymerase Chain Reaction Polymerase Chain Reaction